LASONDRA BEAN: Open Payments
NPI 1710126941 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,503 in 109 payments from 41 companies in 2025. Trend: 2023 $712 · 2024 $2,671 · 2025 $2,503
Food & beverage: $2,202Education: $301
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $254 |
| PFIZER INC. | 12 | $215 |
| Daiichi Sankyo Inc. | 6 | $207 |
| Amgen Inc. | 1 | $201 |
| AstraZeneca Pharmaceuticals LP | 10 | $183 |
| Gilead Sciences, Inc. | 3 | $141 |
| Novartis Pharmaceuticals Corporation | 7 | $138 |
| Merck Sharp & Dohme LLC | 7 | $137 |
| Ipsen Biopharmaceuticals, Inc | 6 | $118 |
| Celgene Corporation | 5 | $108 |
Products named: Enhertu, NPLATE, Trodelvy, KEYTRUDA, Onivyde, DARZALEX, REBLOZYL, RYBREVANT.
Industry payments across KY — which companies pay providers there.
